A preliminary study of the effects of episil(R) oral liquid on chemotherapy- and/or radiation-induced oral mucositis

Not Applicable

• Conditions: Chemotherapy- and/or radiation-induced oral mucositis

• Registration Number: JPRN-UMIN000029244
• Lead Sponsor: Okayama University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-09-26
• Study Completion: 2018-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients have tumor region inside oral cavity 2) Patients have severely injured area not due to oral mucositis 3) Patients who are known or suspected CNS tumor, metastasis or invasion to the CNS 4) Patients have started the rescue medications on Day 1 prior to the application of episil(R) 5) Patients have known allergy to any ingredient in episil(R) 6) Patients who are participating in other clinical trials 7) Female patients who are breast-feeding, pregnancy or planned pregnancy 8) Patients with considerable concern for compliance with the protocol, in the judgment of investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified